But Chargaff’s mocking assessment pointed to another lasting legacy. Asilomar became notable for what the scientists did not discuss there. Their focus was on safety. None of them addressed the big ethical question, the one that Berg had stayed up late discussing in Sicily: How far should we go if and when methods of engineering our genes turned out to be safe?
